| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 80 | 2025 | 1221 | 10.770 |
Why?
|
| Cancer Survivors | 37 | 2024 | 747 | 9.740 |
Why?
|
| Endometrial Neoplasms | 18 | 2023 | 1386 | 3.750 |
Why?
|
| Survivors | 31 | 2024 | 1021 | 3.730 |
Why?
|
| Weight Reduction Programs | 6 | 2022 | 74 | 3.510 |
Why?
|
| Life Style | 23 | 2024 | 617 | 3.300 |
Why?
|
| Self Efficacy | 11 | 2020 | 297 | 2.960 |
Why?
|
| Weight Loss | 9 | 2023 | 628 | 2.900 |
Why?
|
| Health Behavior | 22 | 2024 | 599 | 2.890 |
Why?
|
| Exercise Therapy | 16 | 2025 | 293 | 2.470 |
Why?
|
| Quality of Life | 50 | 2025 | 4810 | 2.280 |
Why?
|
| Health Promotion | 21 | 2024 | 508 | 2.270 |
Why?
|
| Neoplasms | 43 | 2025 | 15951 | 2.230 |
Why?
|
| Diet | 20 | 2024 | 1469 | 2.100 |
Why?
|
| Obesity | 22 | 2024 | 2893 | 2.060 |
Why?
|
| Motivation | 13 | 2024 | 515 | 2.050 |
Why?
|
| Wearable Electronic Devices | 3 | 2022 | 115 | 1.940 |
Why?
|
| Overweight | 11 | 2022 | 484 | 1.690 |
Why?
|
| Breast Neoplasms | 31 | 2024 | 16246 | 1.500 |
Why?
|
| Mobile Applications | 3 | 2021 | 111 | 1.410 |
Why?
|
| Health Status | 9 | 2021 | 626 | 1.190 |
Why?
|
| Feasibility Studies | 16 | 2023 | 2360 | 1.190 |
Why?
|
| Humans | 227 | 2025 | 270804 | 1.180 |
Why?
|
| Uterine Cervical Dysplasia | 7 | 2012 | 209 | 1.140 |
Why?
|
| Self Report | 8 | 2022 | 794 | 1.070 |
Why?
|
| Fitness Trackers | 3 | 2021 | 21 | 1.070 |
Why?
|
| Physical Fitness | 3 | 2019 | 126 | 1.050 |
Why?
|
| Female | 161 | 2025 | 148936 | 1.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 22 | 2020 | 1225 | 1.030 |
Why?
|
| Community Health Services | 2 | 2023 | 127 | 1.020 |
Why?
|
| Middle Aged | 104 | 2025 | 90569 | 1.010 |
Why?
|
| Monitoring, Ambulatory | 2 | 2019 | 61 | 1.000 |
Why?
|
| Surveys and Questionnaires | 42 | 2024 | 5924 | 0.990 |
Why?
|
| Feeding Behavior | 9 | 2023 | 807 | 0.970 |
Why?
|
| Ovarian Neoplasms | 21 | 2023 | 4810 | 0.950 |
Why?
|
| Social Support | 11 | 2020 | 585 | 0.950 |
Why?
|
| Patient Compliance | 9 | 2024 | 677 | 0.940 |
Why?
|
| Colposcopy | 9 | 2012 | 75 | 0.930 |
Why?
|
| Pilot Projects | 18 | 2023 | 2855 | 0.930 |
Why?
|
| Adult | 92 | 2025 | 82073 | 0.920 |
Why?
|
| Small Business | 1 | 2023 | 1 | 0.910 |
Why?
|
| Exercise Tolerance | 3 | 2019 | 106 | 0.900 |
Why?
|
| Uterine Cervical Neoplasms | 15 | 2015 | 1905 | 0.890 |
Why?
|
| Fatigue | 12 | 2025 | 1292 | 0.880 |
Why?
|
| Motor Activity | 6 | 2016 | 710 | 0.860 |
Why?
|
| Spouses | 3 | 2021 | 145 | 0.860 |
Why?
|
| Organizational Culture | 2 | 2024 | 115 | 0.860 |
Why?
|
| Cardiorespiratory Fitness | 3 | 2021 | 20 | 0.820 |
Why?
|
| Attitude to Health | 9 | 2012 | 434 | 0.800 |
Why?
|
| Mass Screening | 12 | 2011 | 1547 | 0.800 |
Why?
|
| Sexual Behavior | 16 | 2013 | 314 | 0.800 |
Why?
|
| Self-Control | 1 | 2022 | 19 | 0.790 |
Why?
|
| Adolescent Behavior | 16 | 2005 | 237 | 0.790 |
Why?
|
| Crowdsourcing | 1 | 2022 | 16 | 0.790 |
Why?
|
| Intra-Abdominal Fat | 2 | 2019 | 94 | 0.780 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2023 | 481 | 0.770 |
Why?
|
| Cooking | 4 | 2023 | 68 | 0.770 |
Why?
|
| Acceptance and Commitment Therapy | 1 | 2021 | 42 | 0.720 |
Why?
|
| Mindfulness | 1 | 2021 | 56 | 0.720 |
Why?
|
| Text Messaging | 1 | 2020 | 33 | 0.720 |
Why?
|
| Affect | 4 | 2020 | 306 | 0.710 |
Why?
|
| Muscle Strength | 2 | 2018 | 104 | 0.710 |
Why?
|
| Ecological Momentary Assessment | 1 | 2020 | 21 | 0.700 |
Why?
|
| Accelerometry | 2 | 2019 | 62 | 0.680 |
Why?
|
| Continuity of Patient Care | 3 | 2022 | 206 | 0.670 |
Why?
|
| Sexually Transmitted Diseases | 10 | 2007 | 106 | 0.670 |
Why?
|
| Sleep | 4 | 2021 | 444 | 0.670 |
Why?
|
| Risk-Taking | 12 | 2013 | 132 | 0.670 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2021 | 232 | 0.660 |
Why?
|
| Aged | 69 | 2025 | 73640 | 0.660 |
Why?
|
| Health Literacy | 1 | 2020 | 119 | 0.650 |
Why?
|
| Nutrition Policy | 1 | 2019 | 108 | 0.640 |
Why?
|
| Telemedicine | 3 | 2023 | 557 | 0.640 |
Why?
|
| Body Weight | 6 | 2020 | 1282 | 0.640 |
Why?
|
| Patient Satisfaction | 7 | 2023 | 924 | 0.640 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 234 | 0.630 |
Why?
|
| Colorectal Neoplasms | 6 | 2023 | 3706 | 0.620 |
Why?
|
| Health Education | 8 | 2022 | 302 | 0.610 |
Why?
|
| Exercise Test | 2 | 2017 | 310 | 0.590 |
Why?
|
| Energy Intake | 2 | 2019 | 517 | 0.570 |
Why?
|
| Pancreatic Neoplasms | 8 | 2024 | 5264 | 0.570 |
Why?
|
| Physical Exertion | 1 | 2017 | 112 | 0.570 |
Why?
|
| Cross-Sectional Studies | 22 | 2024 | 4495 | 0.570 |
Why?
|
| Self Concept | 4 | 2017 | 201 | 0.570 |
Why?
|
| Vaginal Douching | 1 | 2016 | 5 | 0.550 |
Why?
|
| Weight Gain | 1 | 2020 | 463 | 0.550 |
Why?
|
| Stress, Psychological | 10 | 2014 | 1038 | 0.550 |
Why?
|
| Stroke Volume | 1 | 2019 | 550 | 0.550 |
Why?
|
| Patient Care | 1 | 2017 | 148 | 0.540 |
Why?
|
| Urban Population | 1 | 2018 | 275 | 0.540 |
Why?
|
| Disability Evaluation | 1 | 2018 | 242 | 0.540 |
Why?
|
| Reproductive Health | 1 | 2016 | 49 | 0.520 |
Why?
|
| Rural Population | 1 | 2018 | 283 | 0.510 |
Why?
|
| Pain | 7 | 2014 | 1701 | 0.510 |
Why?
|
| HIV Infections | 15 | 2014 | 2155 | 0.510 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 563 | 0.500 |
Why?
|
| Papillomaviridae | 3 | 2016 | 636 | 0.500 |
Why?
|
| Schools | 6 | 2022 | 238 | 0.500 |
Why?
|
| Male | 80 | 2025 | 128520 | 0.490 |
Why?
|
| Depressive Disorder | 2 | 2017 | 567 | 0.490 |
Why?
|
| Patient Education as Topic | 8 | 2020 | 746 | 0.470 |
Why?
|
| Papillomavirus Infections | 3 | 2016 | 999 | 0.450 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 629 | 0.450 |
Why?
|
| Spectrometry, Fluorescence | 6 | 2012 | 206 | 0.450 |
Why?
|
| School Health Services | 7 | 2007 | 112 | 0.450 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 907 | 0.450 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 1437 | 0.440 |
Why?
|
| Health Surveys | 4 | 2019 | 395 | 0.440 |
Why?
|
| Vegetables | 6 | 2022 | 331 | 0.440 |
Why?
|
| Patients | 3 | 2007 | 247 | 0.440 |
Why?
|
| Workplace | 4 | 2022 | 93 | 0.430 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1045 | 0.430 |
Why?
|
| Models, Statistical | 1 | 2019 | 1187 | 0.420 |
Why?
|
| Pregnancy in Adolescence | 7 | 2005 | 59 | 0.420 |
Why?
|
| Food Supply | 2 | 2024 | 101 | 0.420 |
Why?
|
| Depression | 9 | 2016 | 1733 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2024 | 2659 | 0.410 |
Why?
|
| Social Media | 3 | 2024 | 207 | 0.410 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2016 | 551 | 0.410 |
Why?
|
| United States | 27 | 2025 | 15834 | 0.400 |
Why?
|
| Sickness Impact Profile | 3 | 2016 | 138 | 0.400 |
Why?
|
| Deglutition Disorders | 3 | 2024 | 487 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1416 | 0.400 |
Why?
|
| Body Mass Index | 10 | 2019 | 2227 | 0.400 |
Why?
|
| Parent-Child Relations | 1 | 2014 | 266 | 0.400 |
Why?
|
| Texas | 25 | 2024 | 6445 | 0.380 |
Why?
|
| Program Evaluation | 13 | 2013 | 602 | 0.380 |
Why?
|
| Prostatic Neoplasms | 9 | 2020 | 5870 | 0.370 |
Why?
|
| Students | 8 | 2021 | 334 | 0.370 |
Why?
|
| Healthy Lifestyle | 2 | 2023 | 42 | 0.360 |
Why?
|
| High-Intensity Interval Training | 2 | 2021 | 10 | 0.360 |
Why?
|
| Meals | 2 | 2022 | 63 | 0.360 |
Why?
|
| Models, Psychological | 4 | 2019 | 179 | 0.350 |
Why?
|
| Fruit | 5 | 2022 | 303 | 0.340 |
Why?
|
| Psychometrics | 6 | 2016 | 975 | 0.330 |
Why?
|
| Attitude to Death | 2 | 2009 | 103 | 0.330 |
Why?
|
| Anxiety | 6 | 2014 | 1244 | 0.320 |
Why?
|
| Neoadjuvant Therapy | 4 | 2023 | 5247 | 0.310 |
Why?
|
| Testicular Neoplasms | 2 | 2010 | 560 | 0.310 |
Why?
|
| Neoplasms, Glandular and Epithelial | 3 | 2019 | 517 | 0.310 |
Why?
|
| Affective Symptoms | 1 | 2008 | 86 | 0.300 |
Why?
|
| Papanicolaou Test | 5 | 2014 | 116 | 0.300 |
Why?
|
| Video Games | 2 | 2021 | 90 | 0.290 |
Why?
|
| Vaginal Smears | 5 | 2014 | 166 | 0.290 |
Why?
|
| Cohort Studies | 12 | 2023 | 9464 | 0.280 |
Why?
|
| Safe Sex | 3 | 2001 | 19 | 0.280 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 418 | 0.280 |
Why?
|
| Nutrition Surveys | 3 | 2019 | 315 | 0.280 |
Why?
|
| Genital Neoplasms, Female | 4 | 2016 | 794 | 0.280 |
Why?
|
| Smoking | 7 | 2019 | 2549 | 0.270 |
Why?
|
| Research Design | 8 | 2020 | 1562 | 0.270 |
Why?
|
| Men | 1 | 2006 | 8 | 0.270 |
Why?
|
| Spectrum Analysis | 4 | 2012 | 144 | 0.260 |
Why?
|
| Heart Failure | 1 | 2019 | 2331 | 0.260 |
Why?
|
| Adolescent | 34 | 2024 | 32698 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2015 | 601 | 0.250 |
Why?
|
| Linear Models | 3 | 2018 | 1094 | 0.250 |
Why?
|
| Puerto Rico | 4 | 2018 | 63 | 0.250 |
Why?
|
| Patient Selection | 3 | 2015 | 2032 | 0.250 |
Why?
|
| Attitude of Health Personnel | 3 | 2024 | 899 | 0.240 |
Why?
|
| Smoking Prevention | 5 | 2014 | 143 | 0.240 |
Why?
|
| Capacity Building | 1 | 2024 | 29 | 0.240 |
Why?
|
| Postmenopause | 3 | 2021 | 374 | 0.240 |
Why?
|
| Medically Underserved Area | 2 | 2024 | 121 | 0.240 |
Why?
|
| Focus Groups | 5 | 2017 | 282 | 0.240 |
Why?
|
| Walking | 3 | 2019 | 270 | 0.230 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 626 | 0.230 |
Why?
|
| Technology | 2 | 2022 | 100 | 0.230 |
Why?
|
| Sex Education | 3 | 2004 | 23 | 0.230 |
Why?
|
| Prostate-Specific Antigen | 3 | 2007 | 1030 | 0.230 |
Why?
|
| Occupational Health | 3 | 2000 | 92 | 0.230 |
Why?
|
| Neoplasm Staging | 12 | 2020 | 14037 | 0.230 |
Why?
|
| Feedback | 2 | 2022 | 224 | 0.230 |
Why?
|
| Actigraphy | 3 | 2019 | 55 | 0.220 |
Why?
|
| Prebiotics | 1 | 2023 | 34 | 0.220 |
Why?
|
| Safety-net Providers | 1 | 2024 | 55 | 0.220 |
Why?
|
| Sleep Wake Disorders | 2 | 2017 | 371 | 0.220 |
Why?
|
| Behavior | 1 | 2003 | 100 | 0.220 |
Why?
|
| Commerce | 1 | 2023 | 59 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 7789 | 0.220 |
Why?
|
| Physician-Patient Relations | 2 | 2008 | 732 | 0.220 |
Why?
|
| Vitamins | 2 | 2019 | 149 | 0.210 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 972 | 0.210 |
Why?
|
| Mexican Americans | 3 | 2017 | 330 | 0.210 |
Why?
|
| Blood Glucose | 3 | 2022 | 1254 | 0.210 |
Why?
|
| Teaching | 2 | 1994 | 247 | 0.210 |
Why?
|
| Heart Rate | 2 | 2017 | 744 | 0.210 |
Why?
|
| Reaction Time | 2 | 2016 | 233 | 0.210 |
Why?
|
| Educational Status | 5 | 2019 | 387 | 0.210 |
Why?
|
| American Cancer Society | 2 | 2022 | 35 | 0.200 |
Why?
|
| Adaptation, Psychological | 7 | 2010 | 783 | 0.200 |
Why?
|
| Counseling | 4 | 2021 | 380 | 0.200 |
Why?
|
| Pandemics | 2 | 2021 | 1608 | 0.200 |
Why?
|
| Occupational Health Services | 2 | 2000 | 14 | 0.200 |
Why?
|
| Dexamethasone | 2 | 2025 | 1525 | 0.200 |
Why?
|
| Aged, 80 and over | 19 | 2019 | 31117 | 0.200 |
Why?
|
| Hunger | 1 | 2022 | 52 | 0.200 |
Why?
|
| Risk Factors | 18 | 2019 | 17867 | 0.200 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 32 | 0.200 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 1308 | 0.190 |
Why?
|
| Residence Characteristics | 3 | 2019 | 356 | 0.190 |
Why?
|
| Telephone | 2 | 2020 | 163 | 0.190 |
Why?
|
| Adiposity | 3 | 2018 | 238 | 0.190 |
Why?
|
| Clinical Trials as Topic | 7 | 2019 | 3841 | 0.190 |
Why?
|
| Vulnerable Populations | 1 | 2023 | 186 | 0.190 |
Why?
|
| Women's Health | 3 | 2015 | 191 | 0.180 |
Why?
|
| Antineoplastic Agents | 7 | 2025 | 14639 | 0.180 |
Why?
|
| Personal Satisfaction | 2 | 2020 | 130 | 0.180 |
Why?
|
| Qualitative Research | 3 | 2024 | 638 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 359 | 0.180 |
Why?
|
| Treatment Outcome | 13 | 2025 | 33859 | 0.180 |
Why?
|
| Young Adult | 13 | 2021 | 22255 | 0.180 |
Why?
|
| Computers, Handheld | 2 | 2013 | 60 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2019 | 10409 | 0.180 |
Why?
|
| Cannula | 1 | 2020 | 43 | 0.170 |
Why?
|
| Nutrition Therapy | 1 | 2020 | 23 | 0.170 |
Why?
|
| California | 8 | 2004 | 212 | 0.170 |
Why?
|
| Fasting | 1 | 2021 | 334 | 0.170 |
Why?
|
| Health Status Indicators | 3 | 2014 | 230 | 0.170 |
Why?
|
| Models, Theoretical | 3 | 2017 | 800 | 0.170 |
Why?
|
| Body Weight Maintenance | 1 | 2019 | 4 | 0.170 |
Why?
|
| Comorbidity | 5 | 2020 | 2393 | 0.170 |
Why?
|
| Self-Help Groups | 2 | 2011 | 35 | 0.160 |
Why?
|
| Resistance Training | 1 | 2019 | 39 | 0.160 |
Why?
|
| Carotenoids | 1 | 2020 | 104 | 0.160 |
Why?
|
| Energy Metabolism | 2 | 2019 | 985 | 0.160 |
Why?
|
| Public Health | 1 | 2021 | 280 | 0.160 |
Why?
|
| Critical Pathways | 1 | 2020 | 160 | 0.160 |
Why?
|
| Patient Navigation | 1 | 2019 | 33 | 0.160 |
Why?
|
| Attitude | 3 | 1999 | 161 | 0.160 |
Why?
|
| Culture | 2 | 2016 | 104 | 0.160 |
Why?
|
| Sex Factors | 4 | 2019 | 2180 | 0.160 |
Why?
|
| Deglutition | 2 | 2024 | 187 | 0.150 |
Why?
|
| HIV-1 | 4 | 2004 | 636 | 0.150 |
Why?
|
| Marital Status | 2 | 2016 | 89 | 0.150 |
Why?
|
| Cytoreduction Surgical Procedures | 2 | 2019 | 521 | 0.150 |
Why?
|
| Walk Test | 1 | 2018 | 43 | 0.150 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 66 | 0.150 |
Why?
|
| Caregivers | 1 | 2024 | 759 | 0.150 |
Why?
|
| Inflammation | 2 | 2024 | 2491 | 0.150 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 114 | 0.150 |
Why?
|
| Bicycling | 1 | 2017 | 45 | 0.150 |
Why?
|
| Androgen Antagonists | 3 | 2010 | 420 | 0.140 |
Why?
|
| Waist Circumference | 2 | 2014 | 100 | 0.140 |
Why?
|
| Epidemiologic Methods | 1 | 1997 | 249 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2019 | 228 | 0.140 |
Why?
|
| Home Care Services | 2 | 2016 | 99 | 0.140 |
Why?
|
| Nutritional Status | 3 | 2025 | 350 | 0.140 |
Why?
|
| Arousal | 2 | 2015 | 128 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 2051 | 0.140 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 296 | 0.140 |
Why?
|
| Safety Management | 1 | 1998 | 132 | 0.140 |
Why?
|
| Qigong | 1 | 2016 | 12 | 0.140 |
Why?
|
| Intention | 1 | 2017 | 113 | 0.140 |
Why?
|
| CA-125 Antigen | 3 | 2007 | 229 | 0.140 |
Why?
|
| Tai Ji | 1 | 2016 | 16 | 0.140 |
Why?
|
| Glucose | 1 | 2022 | 1213 | 0.140 |
Why?
|
| Folic Acid | 1 | 2019 | 370 | 0.140 |
Why?
|
| Postural Balance | 1 | 2018 | 139 | 0.140 |
Why?
|
| Smoking Cessation | 2 | 2019 | 770 | 0.140 |
Why?
|
| Narrative Therapy | 1 | 2016 | 2 | 0.130 |
Why?
|
| Diet, Fat-Restricted | 1 | 2016 | 52 | 0.130 |
Why?
|
| Substance-Related Disorders | 4 | 1998 | 546 | 0.130 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 15280 | 0.130 |
Why?
|
| Social Environment | 2 | 2016 | 181 | 0.130 |
Why?
|
| Yoga | 1 | 2017 | 88 | 0.130 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 143 | 0.130 |
Why?
|
| Alcohol Drinking | 5 | 2010 | 599 | 0.130 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2016 | 1162 | 0.130 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2017 | 155 | 0.130 |
Why?
|
| Community Networks | 1 | 2015 | 44 | 0.130 |
Why?
|
| Dietary Fiber | 1 | 2016 | 129 | 0.130 |
Why?
|
| Socioeconomic Factors | 5 | 2017 | 1250 | 0.130 |
Why?
|
| Biomarkers | 3 | 2022 | 5050 | 0.130 |
Why?
|
| Prospective Studies | 10 | 2021 | 13422 | 0.130 |
Why?
|
| Negotiating | 1 | 2015 | 14 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 3 | 2024 | 4148 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2018 | 302 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2019 | 686 | 0.120 |
Why?
|
| Food | 1 | 2015 | 151 | 0.120 |
Why?
|
| Mental Health | 2 | 2016 | 408 | 0.120 |
Why?
|
| Medical Oncology | 4 | 2020 | 1464 | 0.120 |
Why?
|
| Education, Continuing | 1 | 1994 | 34 | 0.120 |
Why?
|
| Spirituality | 2 | 2005 | 130 | 0.120 |
Why?
|
| Waiting Lists | 1 | 2016 | 268 | 0.120 |
Why?
|
| Cues | 1 | 2015 | 203 | 0.120 |
Why?
|
| Primary Prevention | 3 | 2019 | 233 | 0.120 |
Why?
|
| Societies, Medical | 3 | 2017 | 1323 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2020 | 930 | 0.120 |
Why?
|
| Remote Sensing Technology | 1 | 2013 | 12 | 0.110 |
Why?
|
| Metformin | 1 | 2018 | 397 | 0.110 |
Why?
|
| Time Factors | 5 | 2013 | 12979 | 0.110 |
Why?
|
| Logistic Models | 7 | 2019 | 3430 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2018 | 1582 | 0.110 |
Why?
|
| Attention | 1 | 2015 | 287 | 0.110 |
Why?
|
| Research Personnel | 1 | 2015 | 165 | 0.110 |
Why?
|
| Eating | 1 | 2016 | 437 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2017 | 4966 | 0.110 |
Why?
|
| Communication | 4 | 2022 | 841 | 0.110 |
Why?
|
| Data Collection | 4 | 2006 | 602 | 0.110 |
Why?
|
| Dehydration | 1 | 2013 | 92 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 1833 | 0.110 |
Why?
|
| Psychological Theory | 1 | 2013 | 44 | 0.110 |
Why?
|
| Secondary Prevention | 2 | 2019 | 312 | 0.110 |
Why?
|
| Risk Reduction Behavior | 2 | 2014 | 210 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2023 | 1385 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2011 | 196 | 0.100 |
Why?
|
| Activities of Daily Living | 3 | 2006 | 555 | 0.100 |
Why?
|
| Employment | 2 | 2003 | 121 | 0.100 |
Why?
|
| Mammaplasty | 2 | 2011 | 714 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2014 | 6234 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2017 | 824 | 0.100 |
Why?
|
| Poverty | 2 | 2014 | 485 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2020 | 1216 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2013 | 340 | 0.100 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 439 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 16751 | 0.100 |
Why?
|
| Cross-Over Studies | 3 | 2020 | 455 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 2395 | 0.090 |
Why?
|
| Hand Strength | 2 | 2023 | 74 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2004 | 6193 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2010 | 666 | 0.090 |
Why?
|
| Minority Groups | 3 | 2020 | 325 | 0.090 |
Why?
|
| Visual Perception | 1 | 2011 | 152 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 2488 | 0.090 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 578 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2014 | 2300 | 0.090 |
Why?
|
| Microscopy, Interference | 2 | 2011 | 16 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 1 | 2017 | 866 | 0.090 |
Why?
|
| Diffusion of Innovation | 3 | 1995 | 142 | 0.090 |
Why?
|
| Decision Making | 3 | 2020 | 1249 | 0.090 |
Why?
|
| Disclosure | 1 | 2011 | 180 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 1993 | 424 | 0.080 |
Why?
|
| Body Composition | 2 | 2018 | 602 | 0.080 |
Why?
|
| Kidney | 1 | 2018 | 2102 | 0.080 |
Why?
|
| Marketing | 1 | 2009 | 15 | 0.080 |
Why?
|
| Mass Media | 1 | 2009 | 35 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2018 | 39982 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 277 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2013 | 4320 | 0.080 |
Why?
|
| Biopsy | 2 | 2008 | 3490 | 0.080 |
Why?
|
| Genotype | 1 | 2016 | 4249 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2014 | 1555 | 0.070 |
Why?
|
| Prostatectomy | 2 | 2010 | 1004 | 0.070 |
Why?
|
| Fear | 1 | 2009 | 259 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 5443 | 0.070 |
Why?
|
| Biomedical Technology | 1 | 2007 | 39 | 0.070 |
Why?
|
| Paper | 1 | 2007 | 13 | 0.070 |
Why?
|
| Mexico | 3 | 2017 | 260 | 0.070 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2013 | 742 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2015 | 1333 | 0.070 |
Why?
|
| Animals | 4 | 2024 | 61362 | 0.070 |
Why?
|
| Endpoint Determination | 1 | 2007 | 180 | 0.070 |
Why?
|
| Cholesterol | 1 | 2010 | 656 | 0.070 |
Why?
|
| Physicians | 1 | 2015 | 854 | 0.070 |
Why?
|
| Psychotherapy, Group | 1 | 2007 | 58 | 0.070 |
Why?
|
| Regression Analysis | 4 | 2003 | 1564 | 0.070 |
Why?
|
| Digital Rectal Examination | 1 | 2006 | 15 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2010 | 2313 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2011 | 800 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2024 | 1825 | 0.070 |
Why?
|
| Sick Role | 1 | 2006 | 72 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2019 | 6766 | 0.070 |
Why?
|
| Violence | 2 | 1998 | 124 | 0.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2019 | 62 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2007 | 136 | 0.070 |
Why?
|
| Somatoform Disorders | 1 | 2006 | 59 | 0.070 |
Why?
|
| Interviews as Topic | 3 | 2013 | 518 | 0.060 |
Why?
|
| Writing | 1 | 2007 | 104 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2007 | 480 | 0.060 |
Why?
|
| Women | 1 | 2005 | 23 | 0.060 |
Why?
|
| Religion | 1 | 2005 | 95 | 0.060 |
Why?
|
| Carboplatin | 2 | 2019 | 890 | 0.060 |
Why?
|
| Emotions | 2 | 2015 | 558 | 0.060 |
Why?
|
| Bevacizumab | 2 | 2019 | 967 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2017 | 4007 | 0.060 |
Why?
|
| Cultural Competency | 2 | 2017 | 70 | 0.060 |
Why?
|
| Optics and Photonics | 1 | 2005 | 165 | 0.060 |
Why?
|
| Pregnancy | 7 | 2005 | 7916 | 0.060 |
Why?
|
| Plant Preparations | 1 | 2004 | 29 | 0.060 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2025 | 219 | 0.060 |
Why?
|
| Food Assistance | 1 | 2024 | 36 | 0.060 |
Why?
|
| Child | 5 | 2020 | 30572 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2006 | 261 | 0.060 |
Why?
|
| Prognosis | 5 | 2018 | 22533 | 0.060 |
Why?
|
| Accidents, Occupational | 1 | 2003 | 10 | 0.060 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2024 | 142 | 0.060 |
Why?
|
| Occupations | 1 | 2003 | 54 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2004 | 101 | 0.050 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2004 | 69 | 0.050 |
Why?
|
| Physical Conditioning, Animal | 1 | 2024 | 112 | 0.050 |
Why?
|
| Lymphedema | 1 | 2006 | 240 | 0.050 |
Why?
|
| Combined Modality Therapy | 5 | 2019 | 9054 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2017 | 10268 | 0.050 |
Why?
|
| Self-Management | 1 | 2024 | 107 | 0.050 |
Why?
|
| ROC Curve | 3 | 2014 | 1250 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 4199 | 0.050 |
Why?
|
| Prevalence | 6 | 2007 | 3395 | 0.050 |
Why?
|
| Testosterone | 1 | 2007 | 638 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 1068 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2007 | 1050 | 0.050 |
Why?
|
| Workload | 1 | 2003 | 193 | 0.050 |
Why?
|
| Faculty | 3 | 2000 | 131 | 0.050 |
Why?
|
| Videoconferencing | 1 | 2021 | 52 | 0.050 |
Why?
|
| Research | 1 | 2003 | 421 | 0.050 |
Why?
|
| Paclitaxel | 2 | 2019 | 2114 | 0.050 |
Why?
|
| Curriculum | 3 | 2000 | 914 | 0.050 |
Why?
|
| Urban Health Services | 1 | 2000 | 34 | 0.050 |
Why?
|
| Adolescent Health Services | 1 | 2000 | 39 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2024 | 530 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2219 | 0.040 |
Why?
|
| Decision Making, Organizational | 2 | 2000 | 8 | 0.040 |
Why?
|
| Psychosexual Development | 1 | 1999 | 3 | 0.040 |
Why?
|
| Family Health | 1 | 2001 | 347 | 0.040 |
Why?
|
| Coitus | 1 | 1999 | 26 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2020 | 117 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 5606 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 907 | 0.040 |
Why?
|
| Hydrazines | 1 | 2021 | 213 | 0.040 |
Why?
|
| Alphapapillomavirus | 2 | 2012 | 172 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2020 | 120 | 0.040 |
Why?
|
| Condoms | 2 | 2001 | 52 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 64 | 0.040 |
Why?
|
| Terminal Care | 1 | 2004 | 467 | 0.040 |
Why?
|
| Patient Participation | 2 | 2020 | 454 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 1999 | 68 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2021 | 450 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2025 | 2575 | 0.040 |
Why?
|
| Speech | 1 | 2000 | 142 | 0.040 |
Why?
|
| Administrative Personnel | 2 | 1995 | 31 | 0.040 |
Why?
|
| Random Allocation | 2 | 1999 | 728 | 0.040 |
Why?
|
| Program Development | 2 | 1999 | 257 | 0.040 |
Why?
|
| Income | 1 | 2019 | 232 | 0.040 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 1345 | 0.040 |
Why?
|
| Occupational Medicine | 1 | 1998 | 3 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 1999 | 352 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 5157 | 0.040 |
Why?
|
| Muscle Stretching Exercises | 1 | 2017 | 14 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 1044 | 0.040 |
Why?
|
| Disease Progression | 1 | 2009 | 6881 | 0.040 |
Why?
|
| Palliative Care | 1 | 2009 | 2177 | 0.040 |
Why?
|
| Gynecology | 2 | 2012 | 233 | 0.040 |
Why?
|
| Dyspnea | 1 | 2020 | 420 | 0.040 |
Why?
|
| Social Behavior | 1 | 1999 | 307 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2023 | 1112 | 0.040 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2017 | 6 | 0.040 |
Why?
|
| Epirubicin | 1 | 2017 | 159 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 51 | 0.040 |
Why?
|
| Life Change Events | 1 | 1997 | 79 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 238 | 0.040 |
Why?
|
| Leisure Activities | 1 | 2016 | 17 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2024 | 1476 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2021 | 720 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 1096 | 0.030 |
Why?
|
| Proteomics | 1 | 2023 | 1426 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 52 | 0.030 |
Why?
|
| Survival Rate | 3 | 2017 | 12535 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2009 | 235 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 9281 | 0.030 |
Why?
|
| Craving | 1 | 2015 | 43 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 5099 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 1656 | 0.030 |
Why?
|
| Breast | 1 | 2021 | 1370 | 0.030 |
Why?
|
| Reoperation | 1 | 2019 | 1391 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 7920 | 0.030 |
Why?
|
| Carcinoma | 1 | 2006 | 2609 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2015 | 217 | 0.030 |
Why?
|
| Decision Trees | 2 | 2005 | 180 | 0.030 |
Why?
|
| Endometrium | 1 | 2018 | 457 | 0.030 |
Why?
|
| Hospitals, Chronic Disease | 1 | 2014 | 2 | 0.030 |
Why?
|
| Reward | 1 | 2015 | 177 | 0.030 |
Why?
|
| Anger | 1 | 2014 | 31 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 850 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1176 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 1996 | 300 | 0.030 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 819 | 0.030 |
Why?
|
| Transportation | 1 | 2014 | 50 | 0.030 |
Why?
|
| Computers | 1 | 2014 | 132 | 0.030 |
Why?
|
| Taxoids | 1 | 2017 | 1019 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 94 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 7054 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2005 | 415 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2013 | 41 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2017 | 1989 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 1993 | 68 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 1083 | 0.030 |
Why?
|
| Video Recording | 1 | 1994 | 284 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2014 | 309 | 0.030 |
Why?
|
| Contraceptive Devices, Male | 1 | 1992 | 3 | 0.030 |
Why?
|
| Age Distribution | 2 | 2004 | 726 | 0.030 |
Why?
|
| Awareness | 1 | 2012 | 113 | 0.020 |
Why?
|
| Cocaine | 1 | 1993 | 243 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 5146 | 0.020 |
Why?
|
| Family Practice | 1 | 2012 | 131 | 0.020 |
Why?
|
| Goals | 1 | 2012 | 186 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 432 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 7323 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2011 | 62 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 2139 | 0.020 |
Why?
|
| Language | 1 | 2013 | 331 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2012 | 160 | 0.020 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 2038 | 0.020 |
Why?
|
| Sexuality | 1 | 2010 | 36 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 2212 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2017 | 3147 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 3246 | 0.020 |
Why?
|
| Aftercare | 1 | 2011 | 250 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 688 | 0.020 |
Why?
|
| Psychosocial Deprivation | 1 | 1998 | 8 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 10731 | 0.020 |
Why?
|
| Organizational Policy | 2 | 2000 | 74 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 1207 | 0.020 |
Why?
|
| Nigeria | 1 | 2007 | 66 | 0.020 |
Why?
|
| Risk | 1 | 1992 | 1931 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 4878 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2007 | 113 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 52 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 6397 | 0.020 |
Why?
|
| Drug Approval | 1 | 2007 | 174 | 0.020 |
Why?
|
| Body Image | 1 | 2007 | 125 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1858 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 326 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6259 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2007 | 420 | 0.020 |
Why?
|
| Breast Self-Examination | 1 | 2005 | 17 | 0.020 |
Why?
|
| Social Conditions | 1 | 2005 | 11 | 0.020 |
Why?
|
| Developing Countries | 1 | 2007 | 315 | 0.020 |
Why?
|
| Ethnology | 1 | 2004 | 3 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 202 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2004 | 86 | 0.020 |
Why?
|
| Medical Records | 1 | 2006 | 441 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2005 | 122 | 0.010 |
Why?
|
| Nausea | 1 | 2006 | 537 | 0.010 |
Why?
|
| Kinetics | 1 | 2007 | 2206 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 168 | 0.010 |
Why?
|
| Education | 1 | 2004 | 125 | 0.010 |
Why?
|
| Mice | 1 | 2024 | 35420 | 0.010 |
Why?
|
| Physical Examination | 1 | 2005 | 306 | 0.010 |
Why?
|
| Truth Disclosure | 1 | 2004 | 178 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 886 | 0.010 |
Why?
|
| Persuasive Communication | 1 | 2001 | 17 | 0.010 |
Why?
|
| Plants, Toxic | 1 | 1999 | 21 | 0.010 |
Why?
|
| Empathy | 1 | 2000 | 103 | 0.010 |
Why?
|
| Tobacco, Smokeless | 1 | 1999 | 29 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2002 | 694 | 0.010 |
Why?
|
| Food Services | 1 | 1999 | 39 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 3908 | 0.010 |
Why?
|
| Mammography | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Computational Biology | 1 | 2005 | 1295 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2002 | 1021 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 15922 | 0.010 |
Why?
|
| Role | 1 | 1997 | 46 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1999 | 481 | 0.010 |
Why?
|
| Peer Group | 1 | 1997 | 141 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1995 | 75 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 1420 | 0.010 |
Why?
|
| Firearms | 1 | 1995 | 45 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 5053 | 0.010 |
Why?
|
| Age of Onset | 1 | 1996 | 853 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1995 | 496 | 0.010 |
Why?
|
| Suicide, Attempted | 1 | 1995 | 130 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2000 | 1875 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 4396 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 5824 | 0.000 |
Why?
|